Report

You have full text access to this OnlineOpen article

Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC

  1. Oscar Rubio-Cabezas1,14,15,†,
  2. Vishwajeet Puri2,†,
  3. Incoronata Murano3,
  4. Vladimir Saudek4,
  5. Robert K. Semple4,
  6. Satya Dash4,
  7. Caroline S. S. Hyden4,
  8. William Bottomley5,
  9. Corinne Vigouroux6,7,8,
  10. Jocelyne Magré6,7,
  11. Philippa Raymond-Barker9,
  12. Peter R. Murgatroyd9,
  13. Anil Chawla2,
  14. Jeremy N. Skepper10,
  15. V. Krishna Chatterjee4,
  16. Sara Suliman11,
  17. Ann-Marie Patch12,
  18. Anil K. Agarwal13,
  19. Abhimanyu Garg13,
  20. Inês Barroso5,
  21. Saverio Cinti3,
  22. Michael P. Czech2,
  23. Jesús Argente1,14,15,
  24. Stephen O'Rahilly4,
  25. David B. Savage4,*

Article first published online: 5 AUG 2009

DOI: 10.1002/emmm.200900037

Issue

EMBO Molecular Medicine

EMBO Molecular Medicine

Volume 1, Issue 5, pages 280–287, August 2009

Additional Information

How to Cite

Rubio-Cabezas, O., Puri, V., Murano, I., Saudek, V., Semple, R. K., Dash, S., Hyden, C. S. S., Bottomley, W., Vigouroux, C., Magré, J., Raymond-Barker, P., Murgatroyd, P. R., Chawla, A., Skepper, J. N., Chatterjee, V. K., Suliman, S., Patch, A.-M., Agarwal, A. K., Garg, A., Barroso, I., Cinti, S., Czech, M. P., Argente, J., O'Rahilly, S. and Savage, D. B. (2009), Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol Med, 1: 280–287. doi: 10.1002/emmm.200900037

Author Information

  1. 1

    Department of Endocrinology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain

  2. 2

    Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA

  3. 3

    Institute of Normal Human Morphology, University of Ancona, Ancona, Italy

  4. 4

    Metabolic Research Laboratories, Institute of Metabolic Science, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK

  5. 5

    Metabolic Disease Group, The Wellcome Trust Sanger Institute, Hinxton, UK

  6. 6

    UPMC Univ Paris 06, UMR_S938, Paris, France

  7. 7

    INSERM, UMR_S938, Faculté de Médecine Pierre et Marie Curie, Site Saint-Antoine, Paris, France

  8. 8

    AP-HP, Hôpital Tenon, Service de Biochimie et Hormonologie, Paris, France

  9. 9

    Wellcome Trust Clinical Research Facility, Addenbrooke's Hospital, Cambridge, UK

  10. 10

    Multi-imaging Centre, Physiology Development & Neuroscience, University of Cambridge, Cambridge, UK

  11. 11

    Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), University of Oxford, Oxford, UK

  12. 12

    Institute of Biomedical and Clinical Science (AM.P.), Peninsula Medical School, Exeter, UK

  13. 13

    Division of Nutrition and Metabolic Diseases, Department of Internal Medicine, Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA

  14. 14

    Department of Pediatrics, Universidad Autónoma de Madrid; Madrid, Spain

  15. 15

    CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain

  1. †

    These authors contributed equally to this work.

*Tel: +44 1223 767923; Fax: +44 1223 330598

Publication History

  1. Issue published online: 5 AUG 2009
  2. Article first published online: 5 AUG 2009
  3. Manuscript Accepted: 2 JUL 2009
  4. Manuscript Revised: 29 JUN 2009
  5. Manuscript Received: 14 APR 2009

Funded by

  • Wellcome Trust (R.K.S., V.K.K.C., S.O'R., D.B.S., W.B., I.B.(WT)). Grant Number: 077016/Z/05/Z
  • CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) from the ‘Instituto de Salud Carlos III’
  • Fundación Endocrinología y Nutrición, Madrid, Spain (J.A.)
  • GlaxoSmithKline (D.B.S.)
  • U.K. NIHR Cambridge Biomedical Research Centre
  • National Institutes of Health. Grant Numbers: DK30898, DK60837, DK54387
  • Biomedical Imaging Core Facility of the University of Massachusetts Diabetes and Endocrinology Center (National Institutes of Health). Grant Number: DK32520
  • Diabetes UK (S.S.)
  • Italian Ministry of University. Grant Number: FIRB RBIN047PZY_000
  • Cofin. PRIN bando 2007
  • Aide aux Jeunes Diabétiques (AJD)
  • Association de Langue Française pour l'Etude du Diabète et des Maladies Métaboliques (ALFEDIAM)
  • French National Institute for Health and Medical Research (INSERM)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (498K)

References

  • Brasaemle DL, Subramanian V, Garcia A, Marcinkiewicz A, Rothenberg A (2009) Perilipin A and the control of triacylglycerol metabolism. Mol Cell Biochem 326: 15-21
  • Chen Z, Guo K, Toh SY, Zhou Z, Li P (2000) Mitochondria localization and dimerization are required for CIDE-B to induce apoptosis. J Biol Chem 275: 22619-22622
  • Frayn KN (2002) Adipose tissue as a buffer for daily lipid flux. Diabetologia 45: 1201-1210
  • Garg A (2004) Acquired and inherited lipodystrophies. N Engl J Med 350: 1220-1234
  • Garg A, Agarwal AK (2009) Lipodystrophies: disorders of adipose tissue biology. Biochim Biophys Acta 1791: 507-513
  • George S, Rochford JJ, Wolfrum C, Gray SL, Schinner S, Wilson JC, Soos MA, Murgatroyd PR, Williams RM, Acerini CL, et al (2004) A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304: 1325-1328
  • Gray SL, Dalla Nora E, Backlund EC, Manieri M, Virtue S, Noland RC, O'Rahilly S, Cortright RN, Cinti S, Cannon B, et al (2006) Decreased brown adipocyte recruitment and thermogenic capacity in mice with impaired peroxisome proliferator-activated receptor (P465L PPARgamma) function. Endocrinology 147: 5708-5714
  • Himms-Hagen J, Melnyk A, Zingaretti MC, Ceresi E, Barbatelli G, Cinti S (2000) Multilocular fat cells in WAT of CL-316243-treated rats derive directly from white adipocytes. Am J Physiol Cell Physiol 279: C670-C681
  • Keller P, Petrie JT, De Rose P, Gerin I, Wright WS, Chiang SH, Nielsen AR, Fischer CP, Pedersen BK, MacDougald OA (2008) Fat-specific protein 27 regulates storage of triacylglycerol. J Biol Chem 283: 14355-14365
  • Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21: 2191-2192
  • Magnusson B, Gummesson A, Glad CA, Goedecke JH, Jernas M, Lystig TC, Carlsson B, Fagerberg B, Carlsson LM, Svensson PA (2008) Cell death-inducing DFF45-like effector C is reduced by caloric restriction and regulates adipocyte lipid metabolism. Metabolism 57: 1307-1313
  • Nelson KM, Weinsier RL, Long CL, Schutz Y (1992) Prediction of resting energy expenditure from fat-free mass and fat mass. Am J Clin Nutr 56: 848-856
  • Nishino N, Tamori Y, Tateya S, Kawaguchi T, Shibakusa T, Mizunoya W, Inoue K, Kitazawa R, Kitazawa S, Matsuki Y, et al (2008) FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. J Clin Invest 118: 2808-2821
  • Puri V, Czech MP (2008) Lipid droplets: FSP27 knockout enhances their sizzle. J Clin Invest 118: 2693-2696
  • Puri V, Konda S, Ranjit S, Aouadi M, Chawla A, Chouinard M, Chakladar A, Czech MP (2007) Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage. J Biol Chem 282: 34213-34218
  • Puri V, Ranjit S, Konda S, Nicoloro SM, Straubhaar J, Chawla A, Chouinard M, Lin C, Burkart A, Corvera S, et al (2008) Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc Natl Acad Sci USA 105: 7833-7838
  • Savage DB, Petersen KF, Shulman GI (2007) Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 87: 507-520
  • Semple RK, Chatterjee VK, O'Rahilly S (2006) PPAR gamma and human metabolic disease. J Clin Invest 116: 581-589
  • Toh SY, Gong J, Du G, Li JZ, Yang S, Ye J, Yao H, Zhang Y, Xue B, Li Q, et al (2008) Up-regulation of mitochondrial activity and acquirement of brown adipose tissue-like property in the white adipose tissue of fsp27 deficient mice. PLoS ONE 3: e2890
  • Traini M, Jessup W (2009) Lipid droplets and adipose metabolism: a novel role for FSP27/CIDEC. Curr Opin Lipidol 20: 147-149
  • Tsukiyama-Kohara K, Poulin F, Kohara M, DeMaria CT, Cheng A, Wu Z, Gingras AC, Katsume A, Elchebly M, Spiegelman BM, et al (2001) Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat Med 7: 1128-1132
  • Woods CG, Cox J, Springell K, Hampshire DJ, Mohamed MD, McKibbin M, Stern R, Raymond FL, Sandford R, Malik Sharif S, et al (2006) Quantification of homozygosity in consanguineous individuals with autosomal recessive disease. Am J Hum Genet 78: 889-896
  • Ye J, Li JZ, Liu Y, Li X, Yang T, Ma X, Li Q, Yao Z, Li P (2009) Cideb, an ER- and lipid droplet-associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B. Cell Metab 9: 177-190
View Full Article with Supporting Information (HTML) Get PDF (498K)